Bill and Melinda Gates Foundation donations made to Rutgers, The State University of NJ

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donor information

ItemValue
Country United States
Wikipedia pagehttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Best overview URLhttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Facebook username gatesfoundation
LinkedIn username bill-&-melinda-gates-foundation
Websitehttps://www.gatesfoundation.org/
Donations URLhttps://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database
Twitter usernamegatesfoundation
Page on philosophy informing donationshttps://www.gatesfoundation.org/What-We-Do
Grant application process pagehttps://www.gatesfoundation.org/How-We-Work/General-Information/Grantseeker-FAQ
Regularity with which donor updates donations datacontinuous updates
Regularity with which Donations List Website updates donations data (after donor update)irregular
Lag with which donor updates donations datamonths
Lag with which Donations List Website updates donations data (after donor update)years
Data entry method on Donations List WebsiteSQL insertion commands generated by script https://github.com/riceissa/gates-foundation-iati-processing

Brief history: The Gates Foundation launched in 2000, with precursors starting in the 1990s, financed by the personal wealth of co-founder Bill Gates from Microsoft. Starting 2005, it scaled up its giving significantly after a large funding commitment from Warren Buffett

Brief notes on broad donor philosophy and major focus areas: See https://www.gatesfoundation.org/Who-We-Are/General-Information/Foundation-Factsheet for the grantmaking areas. The four grantmaking areas are the Global Development Program, Global Health Program, Global Policy and Advocacy, and United States Program. Within the United States Program the focus is on K-12 education, the Internet, and emergency relief

Notes on grant publication logistics: Although the Gates Foundation has a grants database on its website, as well as individual grant pages for every grant, we use the IATI data instead, because it can be processed programmatically (the data on the site does not allow for full data download or easy programmatic processing). This leads to a few problems: first, IATI data does not include grants made in the United States, since it focuses on development assistance (DA) spending. Second, IATI data is updated more infrequently. Third, it may sometimes omit some information that is present in the grants database

Full donor page for donor Bill and Melinda Gates Foundation

Basic donee information

ItemValue
Country

Full donee page for donee Rutgers, The State University of NJ

Donor–donee relationship

Item Value

Donor–donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 10 750,000 1,080,262 95,257 95,257 100,000 100,000 100,000 750,000 757,376 1,511,333 2,132,238 2,518,838 2,737,574
Global health 10 750,000 1,080,262 95,257 95,257 100,000 100,000 100,000 750,000 757,376 1,511,333 2,132,238 2,518,838 2,737,574

Donation amounts by cause area and year

If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.

Note: Cause area classification used here may not match that used by donor for all cases.

Cause area Number of donations Total 2017 2016 2013 2012 2011 2010 2009
Global health (filter this donor) 10 10,802,616.00 1,511,333.00 4,869,812.00 852,633.00 2,518,838.00 850,000.00 100,000.00 100,000.00
Total 10 10,802,616.00 1,511,333.00 4,869,812.00 852,633.00 2,518,838.00 850,000.00 100,000.00 100,000.00

Graph of spending by cause area and year (incremental, not cumulative)

Graph of spending should have loaded here

Graph of spending by cause area and year (cumulative)

Graph of spending should have loaded here

Full list of donations in reverse chronological order (10 donations)

Amount (current USD)Amount rank (out of 10)Donation dateCause areaURLInfluencerNotes
1,511,333.0042017-08-04Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to characterize the penetration and distribution of new TB drug candidates in the lung to guide the selection of optimal regimens for the treatment of TB; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
2,132,238.0032016-09-02Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to test the efficacy of host directed therapy on sterilizing Mtb (Mycobacterium TB) during latent infection and preventing reactivation; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
2,737,574.0012016-08-15Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to enable the discovery and development of more effective, faster acting drug regimens for drug sensitive and drug resistant TB; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
757,376.0052013-07-30Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a rabbit model that mimics the range of human manifestations of pulmonary TB as a platform for evaluating candidate TB vaccines for the ability to induce sterilizing immunity and/or protect against progression to cavitary TB following challeng; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
95,257.00102013-03-27Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop a simple methodology that extracts Mycobacterium tuberculosis from sputum samples, enabling future rapid point-of-care tests for tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
2,518,838.0022012-10-01Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to enable the discovery of effective drug regimens for drug sensitive and drug resistant tuberculosis (TB) disease, by integrating plasma and lesion pharmacokinetic profiling of existing drugs, hits, leads, and clinical development candidates.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
750,000.0062011-10-18Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop a simple methodology that extracts Mycobacterium tuberculosis from sputum samples, enabling future rapid point-of-care tests for tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
100,000.0072011-10-12Global health/basic health carehttps://iatiregistry.org/publisher/bmgf-- to engineer strains of bacteria found in the human gut to produce the vitamin A precursor beta-carotene, and test the hypothesis that vitamin A-deficiency could be controlled and promote healthy growth of children; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
100,000.0072010-09-29Global health/Reproductive health carehttps://iatiregistry.org/publisher/bmgf-- to evaluate the effectiveness of the natural antimicrobial protein subtilosin to not only treat vaginal infections but also act as a spermicidal agent; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
100,000.0072009-02-26Global health/Medical researchhttps://iatiregistry.org/publisher/bmgf-- to develop transgenic tomatoes that express RNAs that targets several relevant viruses. The team will test whether these antiviral RNAs can accumulate in mammals after their ingestion to suppress viral proliferation.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.